Abstract:Circulation, Volume 146, Issue Suppl_1, Page A15700-A15700, November 8, 2022. Cardiac fibroblasts acquire inflammatory, proangiogenic, or matrix-synthetic phenotypes following MI and play a pivotal role in repair and remodeling of the infarcted heart. Members of the Transforming Growth Factor (TGF)β superfamily (including TGFβs and BMPs) are activated following MI and regulate fibroblast phenotype and cardiac fibrosis. Canonical TGFβ signaling is mediated through the receptor-activated Smads: TGF-βs activate Smad2/3, whereas BMPs predominantly stimulate Smad1/5 cascade. Smad3 signaling plays an important role in activation of infarct myofibroblasts; however, the role of the Smad1 pathway remains unknown. We hypothesized that fibroblast-specific actions of Smad1 regulate repair and remodeling in the infarcted myocardium. In a mouse model of non-reperfused infarction, Smad1 was activated in a subset of cardiac myofibroblasts not only by BMPs, but also by all three TGF-β isoforms. TGF-β activation of Smad1 was dependent on both ALK1 and ALK5 signaling. Analysis of single cell RNA-seq data suggested that ALK1 is a marker of a myofibroblast subset exhibiting anti-fibrotic properties. In order to examine the role of fibroblast Smad1 in vivo, we generated mice with myofibroblast-specific Smad1 loss (MFS1KO). Echocardiography showed that MFS1KO mice have accentuated systolic dysfunction and LV dilation 7-28 days after MI(p<0.01, N=13-49). Worse adverse remodeling in infarcted MFS1KO hearts was associated with scar expansion, higher myofibroblast density and accentuated fibrosis. Smad1 knockdown in cardiac fibroblasts increased mRNA levels of structural and matricellular genes while reducing matrix metalloproteinase synthesis. RNA-seq showed that Smad1 loss activates pathways involved in matrix regulation and collagen biosynthesis, and suggested that Smad1 may exert anti-fibrotic actions through inhibition of TGF-β/Smad3 axis, p53, and IL4/STAT6 pro-fibrotic cascades. In conclusion, Smad1 activation in a subset of anti-fibrotic infarct myofibroblasts restrains cardiac fibrosis and protects from adverse remodeling by inhibiting key pro-fibrotic pathways. These findings suggest that Smad1 activation in fibroblasts may be a promising strategy to restrain cardiac fibrosis in infarcted and failing hearts.

Interaction Between Angiotensin II and Smad Proteins in Fibroblasts in Failing Heart and in Vitro

Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling

Angiotensin‐converting Enzyme Inhibitor Works As a Scar Formation Inhibitor by Down‐regulating Smad and TGF‐β‐activated Kinase 1 (TAK1) Pathways in Mice

Angiotensin II type 1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction

Essential Role Of Smad3 In Angiotensin Ii-Induced Vascular Fibrosis

Cathepsin S-mediated Fibroblast Trans-Differentiation Contributes to Left Ventricular Remodelling after Myocardial Infarction.

Abstract 15700: ALK1-Mediated Smad1 Activation in a Myofibroblast Subset Protects the Infarcted Heart From Adverse Remodeling and Excessive Fibrosis

Abstract 298: Flavin Containing Monooxygenase 2 in Cardiac Fibrosis

Smad3 mediates ANG II-induced hypertensive kidney disease in mice.

Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart.

EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling

Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF β/Smad Activation and Cardiac Fibrosis Induced by Angiotensin II

Abstract 374: Smooth Muscle Cell-specific Deletion Of At1a Receptor Attenuates Vascular Fibrosis In Angiotensin Ii-infused Mice

Regulatory Role of TGF-β in Cardiac Myofibroblast Function and Post-MI Cardiac Fibrosis: Key Roles of Smad7 and c-Ski

Integrin subunit β-like 1 mediates angiotensin II-induced myocardial fibrosis by regulating the forkhead box Q1/Snail axis

AT1 Receptor‐specific Down‐regulation of Smad7 Plays a Key Role in Atrial Fibrillation‐Induced Myocardial Fibrosis

Atrial Fibrillation Induces Myocardial Fibrosis Through Angiotensin II Type 1 Receptor–Specific Arkadia-Mediated Downregulation of Smad7

The role of Smad signaling cascades in cardiac fibrosis

Macrophage-Stimulated Cardiac Fibroblast Production Of Il-6 Is Essential For Tgf Beta/Smad Activation And Cardiac Fibrosis Induced By Angiotensin Ii

Abstract MP02: Angiotensin II Mediates Microvascular Rarefaction In Vivo and Exacerbates Endothelial-To-Mesenchymal Transition In Vitro

Angiotensin II mediates hypertensive cardiac fibrosis via an Erbb4-IR-dependent mechanism.